Aurobindo Pharma Limited has informed the Exchange about press release dated 17-Mar-2022 titled Signing of voluntary license for Pfizer Covid19 oral treatment��� nirmatrelvir
Aurobindo Pharma Limited has informed the Exchange about press release dated 17-Mar-2022 titled Signing of voluntary license for Pfizer Covid19 oral treatment��� nirmatrelvir